Ouabain Reverts CUS-Induced Disruption of the HPA Axis and Avoids Long-Term Spatial Memory Deficits.
Jacqueline Alves LeiteAna Maria OrellanaDiana Zukas AndreottiAmanda Midori MatumotoNatacha Medeiros de Souza PortsLarissa de Sá LimaElisa Mitiko KawamotoCarolina Demarchi MunhozCristoforo ScavonePublished in: Biomedicines (2023)
Ouabain (OUA) is a cardiotonic steroid that modulates Na+, K+ -ATPase activity. OUA has been identified as an endogenous substance that is present in human plasma, and it has been shown to be associated with the response to acute stress in both animals and humans. Chronic stress is a major aggravating factor in psychiatric disorders, including depression and anxiety. The present work investigates the effects of the intermittent administration of OUA (1.8 μg/kg) during the chronic unpredictable stress (CUS) protocol in a rat's central nervous system (CNS). The results suggest that the intermittent OUA treatment reversed CUS-induced HPA axis hyperactivity through a reduction in (i) glucocorticoids levels, (ii) CRH-CRHR1 expression, and by decreasing neuroinflammation with a reduction in iNOS activity, without interfering with the expression of antioxidant enzymes. These changes in both the hypothalamus and hippocampus may reflect in the rapid extinction of aversive memory. The present data demonstrate the ability of OUA to modulate the HPA axis, as well as to revert CUS-induced long-term spatial memory deficits.
Keyphrases
- drug induced
- diabetic rats
- high glucose
- traumatic brain injury
- poor prognosis
- stress induced
- oxidative stress
- randomized controlled trial
- binding protein
- liver failure
- high intensity
- intensive care unit
- inflammatory response
- cognitive impairment
- lipopolysaccharide induced
- respiratory failure
- mechanical ventilation
- subarachnoid hemorrhage
- combination therapy